SH3BP5

Chr 3

SH3 domain binding protein 5

Also known as: SAB, SH3BP-5

The protein functions as a guanine nucleotide exchange factor for RAB11A and RAB25, and inhibits BTK kinase activity in B-cell signaling pathways. Mutations cause autosomal recessive developmental and epileptic encephalopathy with microcephaly, typically presenting in early infancy with seizures and severe developmental delays. The gene shows moderate constraint against loss-of-function variants, consistent with its role in critical cellular signaling processes.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 0.59
Clinical SummarySH3BP5
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.30) despite low pLI — interpret in context.
📋
ClinVar Variants
23 unique Pathogenic / Likely Pathogenic· 64 VUS of 106 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.59LOEUF
pLI 0.048
Z-score 2.91
OE 0.30 (0.160.59)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
0.96Z-score
OE missense 0.84 (0.750.93)
226 obs / 270.5 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.30 (0.160.59)
00.351.4
Missense OE0.84 (0.750.93)
00.61.4
Synonymous OE1.17
01.21.6
LoF obs/exp: 6 / 20.0Missense obs/exp: 226 / 270.5Syn Z: -1.40
DN
0.75top 25%
GOF
0.6834th %ile
LOF
0.3259th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

106 submitted variants in ClinVar

Classification Summary

Pathogenic22
Likely Pathogenic1
VUS64
Likely Benign2
Benign1
22
Pathogenic
1
Likely Pathogenic
64
VUS
2
Likely Benign
1
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
22
0
22
Likely Pathogenic
0
0
1
0
1
VUS
2
61
1
0
64
Likely Benign
1
0
1
0
2
Benign
0
0
1
0
1
Total36126090

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

SH3BP5 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →